Efficacy of a cyclophosphamide-procarbazine-antithymocyte serum regimen for prevention of graft rejection following bone marrow transplantation for transfused patients with aplastic anemia.
D000741:Anemia, Aplastic / Q000628:therapy*; D000961:Antilymphocyte Serum / Q000008:administration & dosage*; D001803:Blood Transfusion; D016026:Bone Marrow Transplantation; D003520:Cyclophosphamide / Q000008:administration & dosage*; D004359:Drug Therapy, Combination; D006084:Graft Rejection / Q000187:drug effects*; D006086:Graft vs Host Disease / Q000517:prevention & control; D006801:Humans; D011344:Procarbazine / Q000008:administration & dosage*; D013601:T-Lymphocytes / Q000276:immunology
D000961:Antilymphocyte Serum; D011344:Procarbazine; D003520:Cyclophosphamide